Melissa Baird - Feb 24, 2022 Form 4/A - Amendment Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Operating Officer
Signature
/s/ Soleil Boughton, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
3/17/2022, 07:16 PM
Date Of Original Report
Mar 1, 2022
Previous filing
Dec 17, 2021
Next filing
Mar 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Award $0 +299K $0.00 299K Feb 24, 2022 Class A Common Stock 299K Direct F1
transaction HIMS Stock Option (right to buy) Award $0 +1.66M $0.00 1.66M Feb 24, 2022 Class A Common Stock 1.66M $5.01 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments over 4 years, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), beginning March 15, 2022, subject to the individual's continuous service with the Company.
F2 The number of stock options awarded has been adjusted from the original filing due to administrative error.
F3 The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.